FDA-Approved GoRoga Wearable Shows 85% Success Rate in Reducing Stress Through Cranial Electrotherapy Stimulation
GoRoga, India's first anti-stress wearable using Cranial Electrotherapy Stimulation technology, has demonstrated significant effectiveness in stress and anxiety management according to clinical findings. A psychiatrist reported that 20 minutes of daily use reduced stress levels, with case studies showing improvements in smoking reduction and relief from headaches. A retrospective study of 100 patients revealed 85% experienced reduced stress levels, with 73% continuing use beyond six months. The FDA-approved device, originally patented as RogaLife in the USA, is now available in India through GlobalSpace Technologies Ltd and is being implemented in corporate wellness programs and educational institutions.